Renaissance Technologies LLC Has $2.38 Million Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Renaissance Technologies LLC raised its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 24.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 579,440 shares of the company's stock after buying an additional 115,389 shares during the period. Renaissance Technologies LLC owned 0.50% of Definitive Healthcare worth $2,381,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of DH. Hennion & Walsh Asset Management Inc. boosted its position in shares of Definitive Healthcare by 34.1% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company's stock valued at $209,000 after acquiring an additional 12,946 shares during the period. Barclays PLC boosted its holdings in Definitive Healthcare by 318.8% in the third quarter. Barclays PLC now owns 81,916 shares of the company's stock worth $366,000 after acquiring an additional 62,354 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Definitive Healthcare by 431.7% in the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company's stock worth $993,000 after purchasing an additional 180,323 shares during the last quarter. State Street Corp grew its holdings in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company's stock valued at $6,257,000 after acquiring an additional 317,952 shares in the last quarter. Finally, Quantbot Technologies LP increased its position in Definitive Healthcare by 5,305.5% in the fourth quarter. Quantbot Technologies LP now owns 17,730 shares of the company's stock worth $73,000 after buying an additional 17,402 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently commented on DH shares. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. The Goldman Sachs Group lowered their price objective on shares of Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Finally, Barclays dropped their price objective on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research note on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $5.35.

Definitive Healthcare Stock Performance

DH traded up $0.04 on Thursday, hitting $2.76. 50,594 shares of the company's stock were exchanged, compared to its average volume of 849,833. The stock has a fifty day moving average of $2.88 and a two-hundred day moving average of $3.95. The firm has a market cap of $297.44 million, a PE ratio of -0.89, a P/E/G ratio of 4.06 and a beta of 1.48. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a twelve month low of $2.15 and a twelve month high of $7.47.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. On average, research analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.